1 Min Read
Feb 15 (Reuters) - Athenex Inc:
* ATHENEX MEETS ENROLLMENT TARGET FOR ORAXOL PHASE III CLINICAL TRIAL IN METASTATIC BREAST CANCER
* ATHENEX INC - EXPECTS SECOND INTERIM ANALYSIS IN Q3 OF 2018 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.